Suresh S. Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University (Winship), will serve as the new editor-in-chief of CANCER, a peer-reviewed journal of the American Cancer Society.
A renowned thoracic oncologist and physician scientist, Ramalingam will begin a 5-year editorship beginning on July 1, 2021. Ramalingam is internationally recognized for his research, specifically for the development of individualized therapies for patients with small cell and non-small cell lung cancer.
In his role at Winship, Ramalingam leads integration of the institute's research, clinical and educational components. He is also assistant dean for cancer research at Emory University School of Medicine. Ramalingam has worked with CANCER as the editor for the journal's Chest and Lung Disease, Clinical Trials, and Medical Oncology sections since 2011.
"I am incredibly honored to serve as the new editor-in-chief of CANCER, one of the oldest and most prestigious oncology journals, which is an important global forum for exchange of scientific knowledge thanks to the leadership of my predecessor Dr. Fadlo R. Khuri," says Ramalingam. "I look forward to continuing to position CANCER as a destination journal of major research discoveries and to help the journal grow in reputation and impact."
Ramalingam succeeds Khuri, MD, who leaves the editor-in-chief position after 10 years of service to help increase the journal's visibility among some of the top research journals in the field. During his tenure, submissions to CANCER increased by more than 40 percent and full-text accesses to the journal's online content more than doubled, making it the most downloaded medical journal on Wiley Online Library.
"We are incredibly grateful for all that Dr. Khuri has done to elevate CANCER's esteemed format and reputation within the oncology community as he is praised by his colleagues for his dedication to the journal," says William G. Cance, MD, chief medical and scientific officer, American Cancer Society. "We are excited to continue that legacy and scientific impact of the journal among leading researchers under the new editorship of Dr. Ramalingam."
Ramalingam holds additional titles at Emory University School of Medicine including professor of hematology and medical oncology, director of the Division of Medical Oncology, and the Roberto C. Goizueta Distinguished Chair for Cancer Research.
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.
- Charaighn Sesock, American Cancer Society